Omeros (OMER) Operating Leases (2018 - 2026)
Omeros (OMER) posted Operating Leases of $5.6 million for Q1 2026, down 22.75% sequentially from $7.2 million in Q4 2025, and down 53.13% YoY from $11.9 million in Q1 2025.
Omeros (OMER) Operating Leases (2018 - 2026) Analysis & Trends
Omeros has reported Operating Leases for 9 years, with the latest figure at $5.6 million in Q1 2026.
- Quarterly Operating Leases fell 53.13% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (down 53.13% YoY) and the FY2025 annual result came in at $7.2 million, down 46.2% from the prior year.
- Operating Leases eased to $5.6 million in Q1 2026 per OMER's latest filing, from $7.2 million in the prior quarter.
- Over five years, Operating Leases peaked at $24.5 million in Q2 2022 and troughed at $5.6 million in Q1 2026.
- A 5-year average of $16.4 million and a median of $16.8 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2026: Operating Leases dropped 12.38% in 2023, then plunged 53.13% in 2026.
- Over 5 years, Operating Leases stood at $22.4 million in 2022, then slipped by 19.1% to $18.1 million in 2023, then fell by 25.78% to $13.5 million in 2024, then slumped by 46.2% to $7.2 million in 2025, then dropped by 22.75% to $5.6 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $5.6 million, $7.2 million, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.90 Mn |
| Mar 31, 2026 | 5.60 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 10.38 Mn |
| Mar 31, 2025 | 11.94 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Sep 30, 2024 | 14.24 Mn |
| Jun 30, 2024 | 15.63 Mn |
| Mar 31, 2024 | 16.75 Mn |
| Dec 31, 2023 | 18.14 Mn |
| Sep 30, 2023 | 19.25 Mn |
| Jun 30, 2023 | 20.42 Mn |
| Mar 31, 2023 | 21.29 Mn |
| Dec 31, 2022 | 22.43 Mn |
| Sep 30, 2022 | 23.53 Mn |
| Jun 30, 2022 | 24.52 Mn |
| Mar 31, 2022 | 24.30 Mn |
| Dec 31, 2021 | 34.38 Mn |
| Sep 30, 2021 | 30.29 Mn |